| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.005 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |